Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008-2019.

BACKGROUND: Pneumococcal conjugate vaccines (PCVs) have decreased pneumonia in children. Colombia introduced mass vaccination with PCV10 in 2012. METHODS: Cases of pneumococcal pneumonia from 10 hospitals were included. Two periods were compared: pre-PCV10: 2008-2011 and post-PCV10: 2014-2019. The objective was to compare epidemiological and clinical characteristics before and after PCV10 vaccination. RESULTS: A total of 370 cases were included. Serotypes 1 (15, 11.2%) and 14 (33, 24.6%) were the most frequent in the pre-PCV10 period, with only 4 (3%) cases of serotype 19A and 1 case (0.7%) serotype 3. From the pre-PCV10 period to the post-PCV10 period, cases of serotypes 1 (6, 3.1%) and 14 (1, 7.8%) decreased, while cases of serotypes 19A (58, 30.2%), serotype 3 (32, 16.7%) and 6A (7, 3.6%) increased (p < 0.001); complicated pneumonia (CP) increased significantly (13.4% to 31.8%) (p < 0.001); hospitalizations increased from 8 (5.5-15) to 12 (7-22) days (p < 0.001); and the frequency of PICU admission increased from 32.8% to 51.6% (p = 0.001). The use of ampicillin-sulbactam (0.7% to 24%) and ceftriaxone/clindamycin (0.7% to 5.7%) increased in the post-PCV10 period. The duration of empirical antibiotic treatment was 7 (4-11) days in the pre-PCV10 period and increased to 10 (6-17) days (p < 0.001) in the post-PCV10 period. Lethality showed a slight nonsignificant increase (7.5% vs. 9.9%; p = 0.57) in the post-PCV10 period. CONCLUSIONS: PCV10 significantly decreased cases of serotypes 1 and 14, with an increase in cases of serotypes 19A, 3 and 6A, which were the predominant serotypes and had greater severity (e.g., admission to the PICU, CP and more resistance, with an increase in the use of broad-spectrum antibiotics and longer hospitalization) and subsequently included in PCV13. Current data support national and regional evidence on the importance of replacing PCV10 with a higher valence that includes 19A, such as PCV13, with the aim of reducing circulation, particularly of this serotype.

Determinación de la susceptibilidad a drogas de primera línea en aislamientos de Mycobacterium tuberculosis por la técnica del tubo indicador de crecimiento micobacteriano / Determining the susceptibility to first-line drugs in M. tuberculosis isolates using the mycobacteria growth indicator tube method

Antecedentes: La aparición de aislamientos de Mycobacterium tuberculosis resistentes a los medicamentos ha hecho que se busquen métodos más rápidos y confiables para la determinación de la susceptibilidad a las drogas antituberculosas. Objetivo. Determinación de la susceptibilidad a drogas antituberculosas de primera línea en aislamientos de M. tuberculosis utilizando el método del tubo indicador de crecimiento micobacteriano (MGIT). Material y métodos. Se estudiaron 49 aislamientos de M. tuberculosis procedentes del laboratorio de micobacteriología del departamento de Microbiología de la Universidad Nacional de Colombia. Se evaluó y comparó el método MGIT para la determinación de la resistencia o susceptibilidad a rifampicina, isoniacida, etambutol y estreptomicina con la prueba de oro, el método de las proporciones múltiples (PM). Resultados. Por el método de las PM de los 49 aislamientos, 26 (53.0 por ciento) fueron sensibles a los cuatro antibióticos, 12 (24.5 por ciento) resistentes a un antibiótico y 11 (22.5 por ciento) a más de un antibiótico. Por el método MGIT de los 49 aislamientos, 31 (63.3 por ciento) fueron sensibles a los cuatro antibióticos, ocho (16.3 por ciento) resistentes a un antibiótico y 10 (20.6 por ciento) resistentes a más de un antibiótico. Los porcentajes de concordancia observada oscilaron entre 83.7 y 97.9 por ciento y el índice kappa estuvo entre 0.61 y 0.83 para los diferentes antibióticos analizados. La sensibilidad del método MGIT a rifampicina, isoniacida, etambutol y estreptomicina fue de 88.9, 95.2, 62.5 y 58 por ciento respectivamente y la especificidad fue 97.7, 92.3, 98.8 y 98.4 por ciento respectivamente. Por el método MGIT se aislaron cepas resistentes de M. tuberculosis en un tiempo promedio de 7.85 días...

Background: The appearance of Mycobacterium tuberculosisisolates resistant to drugs has triggered the search for quicker and more reliable methods to determine the susceptibility to anti-tuberculosis drugs. Objective. To evaluate the susceptibility of M. tuberculosis isolates to anti-tuberculosis first line drugs by Mycobacterium growth indicator tube method (MGIT).Materials and methods. Forty-nine isolates of M. tuberculosis were tested, coming from the MycobacteriologyLaboratory of Microbiology Department of the Universidad Nacional de Colombia. The MGIT method wasevaluated and compared in order to determine resistance or susceptibility to rifampicin, isoniazid, ethambutol andstreptomycin with the gold standard method, the multiple proportion method (PM). Results. With the PM method, of 49 isolates, 26 (53.0%) were sensitive to all four antibiotics, 12 (24.5%) wereresistant to one antibiotic and 11 (22.5%) to more than one antibiotic. Using the MGIT method, of 49 isolates,31 (63.3%) were sensitive to all four antibiotics, 8 (16.3%) were resistant to one antibiotic and 10 (20.6%) wereresistant to more than one antibiotic. The concordance percentages observed oscillated between 83.7% and 97.9% and the kappa index was between 0.61 and 0.83 for the different antibiotics analyzed. The sensitivity of the MGIT method to the rifampicin, isoniazid, ethambutol and streptomycin was of 88.9, 95.2, 62.5 and 58% respectively and specifity was of 97.7, 92.3,98.8 y 98.4% respectively. Using the MGIT method, isolates resistant to M. tuberculosis were determined inan average time of 7.85 days...